News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Digoxin Use Associated With Higher Risk of Death for Heart Failure Patients, Kaiser Permanente Study


9/20/2013 10:52:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Digoxin, a drug commonly used to treat heart conditions, was associated with a 72 percent higher rate of death among adults with newly diagnosed systolic heart failure, according to a Kaiser Permanente study that appears in the current online issue of Circulation: Cardiovascular Quality and Outcomes.

1Hey, check out all the research scientist jobs. Post your resume today!

Read at ScienceDaily
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES